Frontiers in Drug Discovery

Metadata for this journal is being automatically enriched from connected scholarly data sources.

Journal information

Publisher

Frontiers

Subjects

basic pharmacology · bioinformatics · cardiology · cheminformatics · clinical pharmacology · Computational Drug Discovery Methods · COVID-19 Clinical Research Studies · Malaria Research and Control · Microbial Natural Products and Biosynthesis · Monoclonal and Polyclonal Antibodies Research · pharmacology · Protein Degradation and Inhibitors · SARS-CoV-2 and COVID-19 Research · Therapeutics. Pharmacology · vaccines and immunoinformatics approaches

Country

CH

Languages

EN

ISSN

—

E-ISSN

2674-0338

ISSN-L

2674-0338

Open access

Yes

OA since

2021

Publication years

2017–2026

APC (summary)

—

Website

—

Journal Classification

Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.

Classification

Multidisciplinary

Primary Field

Multidisciplinary

Primary Subfield

Not assigned for multidisciplinary journals

Domain

—

Confidence

High

Publications classified

59

Classification version

OAJF Classification v1.1

APC records

OPENALEX · 2026

1,950 CHF

DOAJ · 2026

1,950 CHF